IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
Background As the immune system is compromised in patients with cancer, therapeutic strategies to stimulate immunity appear promising, to avoid relapse and increase long-term overall survival. Interleukin-15 (IL-15) has similar properties to IL-2, but does not cause activation-induced cell death nor...
Sparad:
| Huvudupphov: | , , , , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMJ Publishing Group
2020-05-01
|
| Serie: | Journal for ImmunoTherapy of Cancer |
| Länkar: | https://jitc.bmj.com/content/8/1/e000632.full |
| Taggar: |
Inga taggar, Lägg till första taggen!
|